Morepen Laboratories Limited - Laporan Laba Rugi (TTM)

Morepen Laboratories Limited
IN ˙ NSEI
₹ 49.31 ↓ -0.27 (-0.54%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Morepen Laboratories Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 10,380 11,136 11,980 13,295 13,854 14,743 15,558 14,721 14,765 14,270 14,220 15,238 15,433 16,422 16,904 17,571 17,748 17,843 18,116 18,009
Change (%) 7.28 7.58 10.97 4.21 6.42 5.53 -5.38 0.30 -3.35 -0.35 7.16 1.28 6.41 2.93 3.94 1.01 0.53 1.53 -0.59
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6,883 7,370 7,882 8,908 9,251 9,874 10,611 10,105 10,068 9,713 9,750 10,328 10,280 10,732 10,858 11,098 11,096 11,281 11,854 11,808
Change (%) 7.08 6.95 13.01 3.84 6.73 7.47 -4.77 -0.36 -3.53 0.38 5.93 -0.46 4.39 1.17 2.22 -0.02 1.67 5.08 -0.39
% of Revenue 66.31 66.19 65.80 67.01 66.77 66.97 68.20 68.64 68.19 68.06 68.56 67.78 66.61 65.35 64.23 63.16 62.52 63.22 65.43 65.56
Gross Operating Profit 3,497 3,765 4,098 4,386 4,603 4,869 4,947 4,616 4,697 4,557 4,470 4,910 5,153 5,691 6,047 6,472 6,652 6,562 6,262 6,202
Change (%) 7.69 8.82 7.05 4.94 5.79 1.60 -6.69 1.74 -2.96 -1.91 9.83 4.95 10.44 6.25 7.04 2.78 -1.36 -4.57 -0.96
% of Revenue 33.69 33.81 34.20 32.99 33.23 33.03 31.80 31.36 31.81 31.94 31.44 32.22 33.39 34.65 35.77 36.84 37.48 36.78 34.57 34.44
SG&A 1,279 1,345 1,407 2,092 1,589 1,809 1,724 2,604 1,843 1,800 1,654 2,884 1,958 2,127 1,935 1,998 2,017 1,980 2,118 3,230
Change (%) 5.15 4.61 48.63 -24.04 13.89 -4.71 51.04 -29.24 -2.32 -8.10 74.37 -32.12 8.64 -9.00 3.25 0.93 -1.83 6.99 52.47
% of Revenue 12.33 12.08 11.75 15.73 11.47 12.27 11.08 17.69 12.48 12.61 11.63 18.93 12.69 12.95 11.45 11.37 11.37 11.10 11.69 17.94
R&D
Change (%)
% of Revenue
OpEx 9,583 10,190 10,998 12,103 12,584 13,445 14,378 13,828 14,035 13,673 13,659 14,540 14,688 15,361 15,653 15,919 15,916 16,107 16,665 16,673
Change (%) 6.33 7.93 10.04 3.97 6.84 6.94 -3.82 1.49 -2.58 -0.10 6.45 1.02 4.58 1.90 1.70 -0.02 1.20 3.46 0.05
% of Revenue 92.33 91.51 91.81 91.03 90.83 91.20 92.42 93.93 95.06 95.82 96.06 95.42 95.17 93.53 92.60 90.60 89.68 90.27 91.99 92.58
Operating Income 797 946 982 1,192 1,270 1,298 1,180 893 730 597 561 698 745 1,062 1,252 1,651 1,832 1,736 1,451 1,337
Change (%) 18.74 3.79 21.43 6.54 2.22 -9.09 -24.33 -18.24 -18.26 -6.03 24.52 6.73 42.45 17.88 31.95 10.94 -5.26 -16.41 -7.86
% of Revenue 7.67 8.49 8.19 8.97 9.17 8.80 7.58 6.07 4.94 4.18 3.94 4.58 4.83 6.47 7.40 9.40 10.32 9.73 8.01 7.42
Interest Expense -17 -165 -18 -17 -12 -24 -2 -33 -38 -20 -19 -19 -35 -37 -46 -53 -45 -78 -112
Change (%) 848.37 -89.18 -4.27 -29.26 -92.44 1,697.49 16.70 -48.48 -5.65 -0.87 87.52 6.79 23.43 15.73 -15.67 74.20 44.23
% of Revenue -0.17 -1.48 -0.15 -0.13 -0.09 -0.16 -0.01 -0.22 -0.27 -0.14 -0.12 -0.12 -0.21 -0.22 -0.26 -0.30 -0.25 -0.43 -0.62
Net Income 684 814 971 1,082 1,184 1,161 1,017 768 553 428 387 477 531 761 962 1,177 1,313 1,260 1,180 926
Change (%) 18.98 19.34 11.44 9.42 -1.92 -12.43 -24.43 -28.05 -22.66 -9.55 23.28 11.42 43.29 26.33 22.39 11.55 -4.04 -6.32 -21.54
% of Revenue 6.59 7.31 8.10 8.14 8.55 7.88 6.54 5.22 3.74 3.00 2.72 3.13 3.44 4.64 5.69 6.70 7.40 7.06 6.51 5.14

Source: Capital IQ

Other Listings
IN:500288
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista